Guardian

Google DeepMind launches AI tool to help identify genetic drivers of disease

Barrons

Google Unveils AI Tool Probing Mysteries Of Human Genome

Science News

AI tool AlphaGenome predicts how one typo can change a genetic story

Independent

Google unveils AI that can predict how DNA mutations cause disease

Observer (NY)

Meet AlphaGenome, the AI that could predict your cancer

Scientific American

Google DeepMind unleashes new AI AlphaGenome to investigate DNA’s ‘dark matter’

Nature

Advancing regulatory variant effect prediction with AlphaGenome

Science Media Centre

expert reaction to paper on Google DeepMinds AlphaGenome

Digital Watch Observatory

Experts warn over unreliable AI medical guidance

Swiss Medical Weekly

Are we ready for Artificial Intelligence in Medicine?

BBC News

AI model from Google DeepMind reads recipe for life in our DNA

Chemistry World

Googles AlphaGenome wants to do for DNA what AlphaFold did for proteins

Breitbart

Google unveils AI tool probing mysteries of human genome

The Telegraph

Designer Dna Revolutionise Cures Diseases Google Deepmind

GoogleDeepMind

Metaculus

Elon Musk

Rishi Sunak

Kamala Harris

Bill Gates

Andrew Ng

Yoshua Bengio

Fei-Fei Li

Demis Hassabis

Melanie Mitchell

Sam Altman

Dario Amodei

Geoffrey Hinton

Yann LeCun

Gary Marcus

Max Tegmark

Connor Leahy

Eliezer Yudkowsky

Jaan Tallinn

Marc Andreessen

Eric Schmidt

Norbert Wiener

Arthur Clarke

Irving John Good

Claude Shannon

Hans Moravec

John Smart

There's a "wall of fear-mongering and doomerism" in the AI world right now.

"Worrying about AI today is like worrying about overpopulation on Mars."

Concerns that AI could pose a threat to humanity is "preposterously ridiculous."

Claiming AI poses an existential threat is "such an extreme" and risks "wip[ing] out some of its potential benefits."

"I'm more concerned about... the risks that are here and now [than the existential threat of AI]."

Current AI is "not anywhere close" to posing an existential threat but it could in the future.

AI is the "biggest existential threat" to humanity.

AGI's worst-case scenario would be "lights-out for all of us."

Powerful AI systems "taking control" pose an "existential threat."

AI has a "10 to 25 per cent" chance of destroying humanity.

"The most likely result of building a superhumanly smart AI... is that literally everyone on Earth will die."

Does AI Pose an Existential Threat to Humanity?

Stuart Russell

Shane Legg

Society is more likely to get "cat-level" or "dog-level" AI years before human-level AI.

"[W]e will eventually reach AGI... and quite possibly before the end of this century."

"Superhuman AIs" will be achieved "between a few years and a couple of decades."

"Digital intelligence" could overtake us within "5 to 20 years."

We may achieve "something like AGI or AGI-like in the next decade."

"[W]e could get to real AGI in the next decade."

"Human-level" AI could occur in "two or three years."

"I'd be surprised if we don't have AGI by [2029]."

Will AI Surpass Human Intelligence, and When?

Google DeepMind unveiled AlphaGenome, an artificial intelligence model designed to analyze DNA sequences and predict how mutations affect gene regulation and biological processes. The tool can process up to one million DNA base pairs simultaneously and make predictions about thousands of genetic signals in human and mouse genomes.

Google DeepMind unveiled AlphaGenome, an artificial intelligence model designed to analyze DNA sequences and predict how mutations affect gene regulation and biological processes. The tool can process up to one million DNA base pairs simultaneously and make predictions about thousands of genetic signals in human and mouse genomes.

AlphaGenome was trained on public databases containing molecular data from human and mouse genomes, enabling it to predict 5,930 human or 1,128 mouse genetic signals across 11 different biological processes. The model matched or exceeded existing tools in 25 of 26 performance evaluations.

AlphaGenome was trained on public databases containing molecular data from human and mouse genomes, enabling it to predict 5,930 human or 1,128 mouse genetic signals across 11 different biological processes. The model matched or exceeded existing tools in 25 of 26 performance evaluations.

The model demonstrated improved accuracy in predicting effects of genetic variants on gene expression, including eQTLs and splice sites. AlphaGenome increased tissue-weighted mean correlation from 0.39 to 0.49 compared to previous models and showed particular strength in analyzing long-distance regulatory relationships.

The model demonstrated improved accuracy in predicting effects of genetic variants on gene expression, including eQTLs and splice sites. AlphaGenome increased tissue-weighted mean correlation from 0.39 to 0.49 compared to previous models and showed particular strength in analyzing long-distance regulatory relationships.

Researchers suggest AlphaGenome could help identify disease-causing mutations and accelerate drug discovery by analyzing genetic variants associated with conditions including cancer and rare diseases. The tool has been tested by approximately 3,000 scientists from 160 countries since its limited release in June 2024.

Researchers suggest AlphaGenome could help identify disease-causing mutations and accelerate drug discovery by analyzing genetic variants associated with conditions including cancer and rare diseases. The tool has been tested by approximately 3,000 scientists from 160 countries since its limited release in June 2024.

External scientists noted limitations of the model, including that AI predictions depend on training data quality and that existing biological datasets are often too small or poorly standardized. The model cannot yet account for complex environmental factors that influence gene expression in living organisms.

External scientists noted limitations of the model, including that AI predictions depend on training data quality and that existing biological datasets are often too small or poorly standardized. The model cannot yet account for complex environmental factors that influence gene expression in living organisms.

While some researchers praised AlphaGenome as a significant advancement, others expressed skepticism about its practical value compared to AlphaFold, which won the 2024 Nobel Prize in Chemistry. One computational biologist stated the model represents incremental progress rather than a transformative breakthrough.

New York Times

While some researchers praised AlphaGenome as a significant advancement, others expressed skepticism about its practical value compared to AlphaFold, which won the 2024 Nobel Prize in Chemistry. One computational biologist stated the model represents incremental progress rather than a transformative breakthrough.

DeepMind Unveils AlphaGenome AI to Predict Gene Mutations

DeepMind Unveils AlphaGenome AI to Predict Gene Mutations

The Controversies

Andreessen

Ng

LeCun

Mitchell

Li

Bengio

Musk

Altman

Hinton

Amodei

Yudkowsky

LeCun

Marcus

Bengio

Hinton

Hassabis

Altman

Amodei

Musk

Go Deeper

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

DeepMind Unveils AlphaGenome AI to Predict Gene Mutations

DeepMind Unveils AlphaGenome AI to Predict Gene Mutations

The Controversies

Andreessen

Ng

LeCun

Mitchell

Li

Bengio

Musk

Altman

Hinton

Amodei

Yudkowsky

LeCun

Marcus

Bengio

Hinton

Hassabis

Altman

Amodei

Musk

Go Deeper

Sign Up for Our Free NewslettersSign Up for Our Free Newsletters

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters